Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England

Neuro-Oncology

Volumn 11, Issue 4, 2009, Pages 403-413

  Arora, Ramandeep S ^a,d   Alston, Robert D ^a   Eden, Tim O B ^b   Estlin, Edward J ^a   Moran, Anthony ^c   Birch, Jillian M ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cancer registry; Central nervous system; England; Epidemiology; Tumor incidence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 68949085208     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2008-097     Document Type: Article

References (50)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents. Vol. 8. Lyon, France: IARC Press; 2002.
2. Stiller CA, ed. Childhood Cancer in Britain: Incidence, Survival, Mortality. Oxford: Oxford University Press; 2007.
3. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer. 2002;87:1267-1274.
4. Geraci M, Birch JM, Alston RD, Moran A, Eden TO. Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005. Br J Cancer. 2007;97:1588-1594.
5. McKinney PA. Brain tumors: Incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry. 2004;759(suppl 2):ii12-ii17.
6. Strother DR, Pollack IF, Fisher PG, Hunter JV, Woo SY, Pomeroy SL, Rorke LB. Tumors of the central nervous system. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2002:751-824.
7. Ogungbo BI, Najim O, Mendelow AD, Crawford PJ. Epidemiology of adult brain tumors in Great Britain and Ireland. Br J Neurosurg. 2002;16:140-145.
8. Johannesen TB, Angell-Andersen E, Tretli S, Langmark F, Lote K. Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology. 2004;23:101-109.
9. Kaneko S, Nomura K, Yoshimura T, Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: Estimation from the Brain Tumor Registry of Japan, 1973-1993. J Neurooncol. 2002;60:61-69.
10. World Health Organization. International Classification of Tumors No. 21. Histological Typing of Tumors of the Central Nervous System. Geneva: WHO Offset Publication; 1979.
11. Kleihues P, Burger PC, Scheihauer BW, eds. Histological Typing of Tumors of the Central Nervous System. World Health Organization International Histological Classification of Tumors. 2nd ed. Berlin: Springer; 1993.
12. Committee of Brain Tumor Registry of Japan. Special Report of Brain Tumour Registry of Japan (1969-1990). Neurol Med Chir Tokyo. 1999;39:59-107.
13. Peris-Bonet R, Martínez-García C, Lacour B, et al. Childhood central nervous system tumors - incidence and survival in Europe (1978-1997): Report from Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2064-2080.
14. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Available at http://www.cbtrus.org/reports//2005-2006/2006report.pdf. Accessed March 5, 2008.
15. Kleihues P, Cavenee WK, eds. WHO Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. Lyon, France: IARC Press; 2000.
16. Office for National Statistics. Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2005, England. Available at http://www.statistics.gov.uk/dwonloads/theme-health/MB1-36/MB1 -No36-2005.pdf. Accessed April 10, 2008.
17. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology (ICD-O). 2nd ed. Geneva: World Health Organization; 1990.
18. Bendel A, Beaty O III, Bottom K, Bunin G, Wrensch M. Central nervous system cancer. In: Bleyer A, O'Leary M, Barr R, Ries LAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006:65-80. Available at http://seer.cancer.gov/publications/aya/6-cns.pdf. Accessed February 8, 2008.
19. van der Sanden GA, Schouten LJ, van Dijck JA, van Andel JP, van der Maazen RW, Coebergh JW. Primary central nervous system lymphomas: Incidence and survival in the southern and eastern Netherlands. Cancer. 2002;94:1548-1556.
20. Ferreri AJ, Reni M, Zoldan MC, Terreni MR, Villa E. Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion. Cancer. 1996;77:827-833.
21. O'Neill BP, Dinapoli RP, Kurtin PJ, Habermann TM. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): How much staging is enough? J Neurooncol. 1995;25:67-71.
22. Jahnke K, Hummel M, Korfel A, et al. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. J Clin Oncol. 2006;24:4754-4757.
23. Cancer incidence and mortality in the United Kingdom and constituent countries, 2002-04. Health Stat Q. 2007;35:78-83.
24. Lönn S, Klaeboe L, Hall P, et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer. 2004;108:450-455.
25. ACCIS. Automated Childhood Cancer Information System Database. Available at http://www-dep.iarc.fr/accis/.htm. Accessed February 8, 2008.
26. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Available at http://www.cbtrus.org/reports//2007 -2008/2007report. pdf. Accessed September 1, 2008.
27. Perry A. Pathology of low-grade gliomas: An update of emerging concepts. Neuro-Oncology. 2003;5:168-178.
28. WHO. International Classification of Diseases for Oncology (ICD-O). 1st ed. Geneva: World Health Organization; 1976.
29. Fritz A, Percy C, Jack A, et al., eds. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: World Health Organization; 2000.
30. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System. Lyon, France: IARC Press; 2000.
31. Alston RD, Newton R, Kelsey A, et al. Childhood medulloblastoma in northwest England 1954 to 1997: Incidence and survival. Dev Med Child Neurol. 2003;45:308-314.
32. McNeil DE, Coté TR, Clegg L, Rorke LB. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER update. Surveillance Epidemiology and End Results. Med Pediatr Oncol. 2002;39(3):190-194.
33. Annegers JF, Coulam CB, Abboud CF, Laws ER Jr, Kurland LT. Pituitary adenoma in Olmsted County, Minnesota, 1935-1977. A report of an increasing incidence of diagnosis in women of childbearing age. Mayo Clin Proc. 1978;53:641-643.
34. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf). 1994;41:359-364.
35. Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary tumour registry: A novel clinical resource. J Clin Endocrinol Metab. 2000;85:168-174.
36. Cuccia V, Galarza M. Pure pineal germinomas: Analysis of gender incidence. Acta Neurochir (Wein). 2006;148:865-871.
37. Mørk SJ, Lindegaard KF, Halvorsen TB, et al. Oligodendroglioma: Incidence and biological behavior in a defined population. J Neurosurg. 1985;63:881-889.
38. Jaskólsky D, Zawirski M, Papierz W, Kotwica Z. Mixed gliomas. Their clinical course and results of surgery. Zentralbl Neurochir. 1987;48:120-123.
39. Reni M, Gatta G, Mazza E, Vecht C. Ependymoma. Crit Rev Oncol Hematol. 2007;63:81-89.
40. Schiffer D, Chiò A, Giordana MT, et al. Histologic prognostic factors in ependymoma. Childs Nerv Syst. 1991;7(4):177-182.
41. Howitz MF, Johansen C, Tos M, Charabi S, Olsen JH. Incidence of vestibular schwannoma in Denmark, 1977-1995. Am J Otol. 2000;21:690-694.
42. Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas. Laryngoscope. 1999;109:736-740.
43. Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology. 2006;8:1-11.
44. Klaeboe L, Lonn S, Scheie D, et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer. 2005;117(6):996-1001.
45. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991: Incidence, survival, and mortality. J Clin Endocrinol Metab. 2000;85:1420-1425.
46. Modan B, Wagener DK, Feldman JJ, Rosenberg HM, Feinleib M. Increased mortality from brain tumors: A combined outcome of diagnostic technology and change of attitude toward the elderly (erratum in Am J Epidemiol 1992;136:622). Am J Epidemiol. 1992;135:1349-1357.
47. Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro-Oncology. 2006;8:27-37.
48. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro-Oncology. 2002;4:278-299.
49. Office for National Statistics. Census, April 2001. Available at http://www.statistics.gov.uk/cci/nugget.asp?id=273. Accessed September 2, 2008.
50. US Census Bureau. 2006 American Community Survey. Available at http://factfinder.census.gov/servlet/DTTable?-bm=y&-geo-id=01000US& -ds-name=ACS-2006-EST-G00-&-mt-name=ACS-2006-EST -G2000-B02001. Accessed September 2, 2008.